Lundbeck agrees to buy migraine drug producer Alder for $2 billion

Lundbeck, a Danish pharma company focused on brain disease, agreed to buy Alder BioPharmaceuticals, a Bothell, Washington-based developer of migraine drugs, for almost $2 billion in cash. Why it matters: This is the patent cliff in practice. Lundbeck soon wi…

Lundbeck agrees to buy migraine drug producer Alder for $2 billion

Lundbeck, a Danish pharma company focused on brain disease, agreed to buy Alder BioPharmaceuticals, a Bothell, Washington-based developer of migraine drugs, for almost $2 billion in cash.
Why it matters: This is the patent cliff in practice. Lundbeck soon wi…
Read More

Do NOT follow this link or you will be banned from the site!